Baxter International scored an exit as dialysis machine developer Outset Medical floated above its range in an upsized offering.

Outset Medical, a US-based dialysis system provider backed by medical device manufacturer Baxter International, is going public today in an initial public offering sized at approximately $242m. The IPO will consist of 8.95 million shares issued on the Nasdaq Global Select Market and priced at $27.00 each, above the $22 to $24 range the company…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.